HUNTER SYNDROME

Clinical trials for HUNTER SYNDROME explained in plain language.

Never miss a new study

Get alerted when new HUNTER SYNDROME trials appear

Sign up with your email to follow new studies for HUNTER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 3 Completed 1

Extended hope: Year-Long study tests rare disease treatment

Disease control Completed

This study followed patients with Hunter syndrome for about one year to check the long-term safety and effectiveness of Hunterase enzyme replacement therapy. It included 30 patients who had already been receiving this treatment for at least six months. Researchers monitored walki…

Matched conditions: HUNTER SYNDROME

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated Mar 09, 2026 14:24 UTC

HUNTER SYNDROME

Get alerted when new HUNTER SYNDROME trials appear

Extended hope: Year-Long study tests rare disease treatment